- Services
We have
the expertise
We have the right expertise when you need it. We help our clients maximise the value of their brands, technologies and designs.
- Sectors
We know
your sector
Our teams work across multiple sectors and have a deep understanding of the latest trends and challenges facing businesses. This enables us to be your trusted advisers.
- Food & beverage
- IT & software
- Life sciences & chemistry
- Medical devices
- Pharmaceuticals
- Semiconductors
- People
We have
the right people
Our people are experts in their field who have deep, practical and hands-on experience. We take the time to really understand our clients and their business so we can provide commercial, jargon-free advice.
- Insights & events
News, insights & events
Find out the latest IP news, insights and events Mathys & Squire is talking about.
- Services
We have
the expertise
We have the right expertise when you need it. We help our clients maximise the value of their brands, technologies and designs.
- Sectors
We know
your sector
Our teams work across multiple sectors and have a deep understanding of the latest trends and challenges facing businesses. This enables us to be your trusted advisers.
- Food & beverage
- IT & software
- Life sciences & chemistry
- Medical devices
- Pharmaceuticals
- Semiconductors
- People
We have
the right people
Our people are experts in their field who have deep, practical and hands-on experience. We take the time to really understand our clients and their business so we can provide commercial, jargon-free advice.
- Insights & events
News, insights & events
Find out the latest IP news, insights and events Mathys & Squire is talking about.
Latest news
IP trends for 2020: innovation in the food industry
In line with recent public appetite for healthier living and sustainability, the expected trends for 2020 focus mainly on foods that improve our health and help the planet This article highlights read more…
Importance of IP protection as London and UK tech sector sees record year of VC funding
It was announced last week that total venture capital (VC) funding for London’s tech companies rose by an unprecedented 87% last year to reach $97bn, over double that raised in Berlin and triple read more…
EPO Board of Appeal rejects proposed changes in European priority practice and confirms revocation of important CRISPR patent
At a packed hearing in Munich, Board 338 in five-member form upheld the decision of the Opposition Division revoking EP-B-2771468 – an important CRISPR patent belonging to the Broad Institute, MIT read more…
What does R&D mean and how can it help to fund your business?
In this article for Business & Innovation Magazine, Vicki Strachan, head of our Oxford office, talks to TBAT Innovation about R&D Tax Credits Research & Development (R&D) Tax read more…
IP protection in fast-moving global markets: medical cannabis & CBD
In this article for Open Access Government, Laura Clews, managing associate at Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector In read more…
Conversant welcomes latest Huawei/ZTE SEP ruling
In this article for World IP Review, Mathys & Squire partner Peter Gray provides his expert commentary on the recent High Court decision regarding Conversant Wireless’ patent read more…
Exploiting intellectual property rights in the UK’s food and drink sector
In this article for AgFunderNews, Mathys & Squire partner Michael Stott highlights the importance of food and drink companies protecting their intellectual property in order to prevent read more…
JUVE Patent recommends Mathys & Squire in its 2020 UK rankings
Mathys & Squire has been recognised by JUVE Patent in its inaugural UK rankings The guide brings together UK patent practices, solicitors and barristers, who, according to the in-depth research read more…
The drive for healthier chocolate creates opportunities for IP
Many companies within the food and drink industry are searching for the most effective ways to reformulate their products in response to consumer demands for healthier consumables, along with the read more…
What the US-UK trade deal documents actually reveal
Generics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents Pharma insiders read more…
Mathys & Squire Newsletter
xSign up to our mailing list to receive Mathys Matters, our monthly newsletter which includes the latest news, industry insights and case law.
Please select your areas of interest:
If you would like to change your details, email preferences or unsubscribe, please click on the ‘maintain details’ link in the header of our mailings. For any other queries, please contact [email protected]
This website uses cookies to ensure you get the best experience on our website
Learn more or Opt out - Sectors
- Sectors
